Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Current Assets (2019 - 2025)

Silo Pharma (SILO) has disclosed Current Assets for 7 consecutive years, with $7.4 million as the latest value for Q4 2025.

  • Quarterly Current Assets rose 3.88% to $7.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.4 million through Dec 2025, up 3.88% year-over-year, with the annual reading at $7.4 million for FY2025, 3.88% up from the prior year.
  • Current Assets hit $7.4 million in Q4 2025 for Silo Pharma, up from $6.2 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $12.9 million in Q3 2022 to a low of $5.0 million in Q2 2021.
  • Historically, Current Assets has averaged $8.4 million across 5 years, with a median of $8.0 million in 2024.
  • Biggest five-year swings in Current Assets: surged 1257.5% in 2021 and later crashed 37.21% in 2024.
  • Year by year, Current Assets stood at $10.4 million in 2021, then rose by 11.24% to $11.6 million in 2022, then crashed by 33.62% to $7.7 million in 2023, then dropped by 7.42% to $7.1 million in 2024, then grew by 3.88% to $7.4 million in 2025.
  • Business Quant data shows Current Assets for SILO at $7.4 million in Q4 2025, $6.2 million in Q3 2025, and $6.4 million in Q2 2025.